Results 131 to 140 of about 8,117 (271)

Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use

Therapeutics and Clinical Risk Management, 2018
Diego Jose Maselli,1 Linda Rogers,2 Jay I Peters1 1Division of Pulmonary Diseases and Critical Care, University of Texas Health, San Antonio, TX, USA; 2Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine Mount Sinai &ndash ...
Maselli DJ, Rogers L, Peters JI
doaj  

Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study [PDF]

Background: Following the results of the MANDARA trial, this real-life study aimed at comparing the effectiveness and safety profile of mepolizumab versus benralizumab in a European EGPA cohort.
Baldini C., Berti A., Bettiol A., Bianchi F. C., Cameli P., Caminati M., Cathebras P., Cinetto F., Cohen Tervaert J. W., Coppola A., Costanzo G., Cottin V., Crimi C., Del Giacco S., Desaintjean C., Egan A., Emmi G., Espigol-Frigole G., Folci M., Fornaro M., Franceschini F., Govoni M., Groh M., Guarnieri G., Hellmich B., Iannone F., Jayne D., Jones R., Kernder A., Lo Gullo A., Lombardi C., Lopalco G., Losappio L., Marchi M. R., Marvisi C., Mattioli I., Maule M., Mohammad A. J., Moi L., Monti S., Moosig F., Moroncini G., Negrini S. M., Neumann T., Nolasco S., Novikov P., Padoan R., Rivera C. M., Roccatello D., Salvarani C., Samson M., Schroeder J. W., Seeliger B., Sinico R. A., Solans R., Tcherakian C., Toniati P., Treppo E., Trivioli G., Urban M. L., Vacca A., Vaglio A.   +61 more
core   +1 more source

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

The Lancet, 2023
David J Jackson, L. Heaney, M. Humbert, B. Kent, A. Shavit, Lina Hiljemark, L. Olinger, David Cohen, A. Menzies-Gow, Stephanie Korn, Claus Kroegel, Cristiano Caruso, Ilaria Baglivo, S. Colantuono, David J Jackson, D. Skowasch, Fabiano Di Marco, F. Couturaud, F. Käßner, Iwona Cwiek, Markus Teber, Kornelia Knetsch, Jasmin Preuß, G. Devouassoux, Katrin Milger-Kneidinger, L. Heaney, Lukas Jerrentrup, M. Jandl, Hartmut Timmermann, Beatrice Probst, Maria D’Amato, Martin Hoffmann, Philippe Bonniaud, G. Beltramo, P. Girodet, Patrick Berger, Shuaib M Nasser, Stéphanie Fry, Sven P. Aries, Thomas Koehler, Timothy Harrison   +40 more
semanticscholar   +1 more source

PRS10 COST-UTILITY ANALYSIS OF MEPOLIZUMAB VERSUS BENRALIZUMAB FOR SEVERE EOSINOPHILIC ASTHMA IN THE COLOMBIAN HEALTHCARE SYSTEM [PDF]

, 2020
Elena Vázquez Rodríguez, C.Y. García Núncira   +1 more
openalex   +1 more source

P9‐81: A case of mepolizumab‐tolerant allergic bronchopulmonary aspergillosis successfully switching to benralizumab [PDF]

, 2021
Retno Ariza, Soeprihatini Soemarwoto, Syazili Mustofa, Diyan Ekawati, Hetti Rusmini, Marisa Anggraini, Eriska Rohman, Chiyako Oshikata, Takeshi Kaneko, Naomi Tsurikisawa   +9 more
openalex   +1 more source

Forced Oscillatory Parameters Improved After Benralizumab Treatment in Severe Asthma [PDF]

, 2020
Toshihiro Shirai, T Akamatsu, Keita Hirai, Hiromasa Nakayasu, Kanami Tamura, Toshihiro Masuda, Shingo Takahashi, Yuriko Tanaka, Hiroko Watanabe, Yutaro Kishimoto, Kyohei Oishi, M Saigusa, Akira Yamamoto, Satoru Morita, Kazuhiro Asada   +14 more
openalex   +1 more source

P9‐41: Analysis of benralizumab on humanized IL‐33‐mediated asthma model [PDF]

, 2021

openalex   +1 more source

Successful discontinuation of corticosteroids through remission induction therapy with benralizumab for chronic eosinophilic pneumonia

Respirology Case Reports
Chronic eosinophilic pneumonia (CEP) is an eosinophilic lung disease. Treatment for CEP includes corticosteroids; however, CEP often recurs. A 53‐year‐old woman was referred to our hospital because of poorly controlled asthma.
Y. Kai, Ryosuke Kataoka, Kentaro Suzuki, Eriko Nakamura, Masato Takano, S. Muro   +5 more
semanticscholar   +1 more source

Benralizumab Reduces Exacerbations in Japanese Patients with Severe, Uncontrolled Asthma: Subgroup Analysis of the Calima Trial [PDF]

, 2017
J Mark FitzGerald, Ken Ohta, Mitsuru Adachi, Yuji Tohda, Tadashi Kamei, Motokazu Kato, Masayuki Takanuma, Tadahiro Kakuno, Nobuyuki Imai, Yanping Wu, Magnus Aurivillius, Mitchell Goldman   +11 more
openalex   +1 more source

Changes of the Levels of Eosinophil-Derived Protein in Sputum with Response to Benralizumab in the Patients with Severe Asthma [PDF]

, 2020
Yosuke Kimura, Toshiyuki Koya, Takafumi Hasegawa, M. Toyama, Keisuke Tsukioka, Manabu Hayashi, Toshiaki Kikuchi   +6 more
openalex   +1 more source